Your browser doesn't support javascript.
loading
Leukemia inhibitory factor impairs structural and neurochemical development of rat visual cortex in vivo.
Engelhardt, Maren; di Cristo, Graziella; Grabert, Jochen; Patz, Silke; Maffei, Lamberto; Berardi, Nicoletta; Wahle, Petra.
Afiliación
  • Engelhardt M; Developmental Neurobiology, Faculty of Biology and Biotechnology, Ruhr-University Bochum, Germany; Institute of Neuroanatomy, Medical Faculty Mannheim, CBTM, Heidelberg University, Germany.
  • di Cristo G; Institute of Neuroscience CNR, Pisa, Italy; CHU Sainte-Justine Research Center and Department of Pediatrics, Université de Montréal, Montreal, QC, Canada.
  • Grabert J; Developmental Neurobiology, Faculty of Biology and Biotechnology, Ruhr-University Bochum, Germany.
  • Patz S; Developmental Neurobiology, Faculty of Biology and Biotechnology, Ruhr-University Bochum, Germany; Research Unit for Experimental Neurotraumatology, Department of Neurosurgery, Medical University of Graz, Graz, Austria.
  • Maffei L; Institute of Neuroscience CNR, Pisa, Italy.
  • Berardi N; Institute of Neuroscience CNR, Pisa, Italy.
  • Wahle P; Developmental Neurobiology, Faculty of Biology and Biotechnology, Ruhr-University Bochum, Germany. Electronic address: petra.wahle@ruhr-uni-bochum.de.
Mol Cell Neurosci ; 79: 81-92, 2017 03.
Article en En | MEDLINE | ID: mdl-28088609
Minipump infusions into visual cortex in vivo at the onset of the critical period have revealed that the proinflammatory cytokine leukemia inhibitory factor (LIF) delays the maturation of thalamocortical projection neurons of the lateral geniculate nucleus, and tecto-thalamic projection neurons of the superior colliculus, and cortical layer IV spiny stellates and layer VI pyramidal neurons. Here, we report that P12-20 LIF infusion inhibits somatic maturation of pyramidal neurons and of all interneuron types in vivo. Likewise, DIV 12-20 LIF treatment in organotypic cultures prevents somatic growth GABA-ergic neurons. Further, while NPY expression is increased in the LIF-infused hemispheres, the expression of parvalbumin mRNA and protein, Kv3.1 mRNA, calbindin D-28k protein, and GAD-65 mRNA, but not of GAD-67 mRNA or calretinin protein is substantially reduced. Also, LIF treatment decreases parvalbumin, Kv3.1, Kv3.2 and GAD-65, but not GAD-67 mRNA expression in OTC. Developing cortical neurons are known to depend on neurotrophins. Indeed, LIF alters neurotrophin mRNA expression, and prevents the growth promoting action of neurotophin-4 in GABA-ergic neurons. The results imply that LIF, by altering neurotrophin expression and/or signaling, could counteract neurotrophin-dependent growth and neurochemical differentiation of cortical neurons.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Corteza Visual / Factor Inhibidor de Leucemia / Neurogénesis Idioma: En Revista: Mol Cell Neurosci Asunto de la revista: BIOLOGIA MOLECULAR / NEUROLOGIA Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Corteza Visual / Factor Inhibidor de Leucemia / Neurogénesis Idioma: En Revista: Mol Cell Neurosci Asunto de la revista: BIOLOGIA MOLECULAR / NEUROLOGIA Año: 2017 Tipo del documento: Article